Sunrest Lifescience Ltd

Sunrest Lifescie Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sunrest Lifescience Ltd

₹ 56.7 -7.05%
20 Jun - close price
Company website NSE - SME: SUNREST
About

Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]

Key Points

Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste

Website NSE - SM
  • Market Cap ₹ 24.3 Cr.
  • Current Price ₹ 56.7
  • High / Low ₹ 75.0 / 44.6
  • Stock P/E 12.2
  • Book Value ₹ 34.4
  • Dividend Yield 0.00 %
  • ROCE 14.3 %
  • ROE 14.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost
  • Company has high debtors of 165 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Sep 2024
12.48 15.39
10.82 14.48
Operating Profit 1.66 0.91
OPM % 13.30% 5.91%
0.00 0.00
Interest 0.01 0.12
Depreciation 0.05 0.01
Profit before tax 1.60 0.78
Tax % -24.38% 24.36%
1.99 0.58
EPS in Rs 6.63 1.35
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
10.64 15.79 24.60 24.64 29.48 33.12
10.49 15.51 23.49 21.74 28.57 30.12
Operating Profit 0.15 0.28 1.11 2.90 0.91 3.00
OPM % 1.41% 1.77% 4.51% 11.77% 3.09% 9.06%
0.00 0.00 0.02 0.03 0.00 0.00
Interest 0.00 0.01 0.02 0.06 0.22 0.30
Depreciation 0.02 0.04 0.06 0.13 0.10 0.09
Profit before tax 0.13 0.23 1.05 2.74 0.59 2.61
Tax % 76.92% 21.74% 25.71% 25.55% 61.02% 23.37%
0.04 0.17 0.78 2.04 0.23 2.00
EPS in Rs 40.00 170.00 780.00 6.80 0.54 4.66
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 26%
3 Years: 10%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: 119%
3 Years: 38%
TTM: 770%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -10%
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 17%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.01 0.01 0.01 3.00 4.29 4.29
Reserves 0.12 0.28 1.06 0.11 9.89 10.48
2.27 2.31 3.24 2.14 6.16 5.45
3.85 6.88 8.71 11.47 4.82 6.93
Total Liabilities 6.25 9.48 13.02 16.72 25.16 27.15
0.03 0.15 0.47 0.35 0.26 0.04
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.02 0.02 0.00
6.22 9.33 12.55 16.35 24.88 27.11
Total Assets 6.25 9.48 13.02 16.72 25.16 27.15

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.90 0.15 -0.44 1.15 -14.80 1.43
-0.01 -0.16 -0.36 -0.03 -0.01 -1.14
1.11 0.04 0.90 -1.15 14.64 -0.30
Net Cash Flow 0.20 0.03 0.11 -0.03 -0.16 -0.01

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 184.22 171.06 138.73 160.87 185.72
Inventory Days 23.71 48.88 48.05 96.71 92.25
Days Payable 174.84 206.14 165.68 211.59 69.42
Cash Conversion Cycle 33.08 13.80 21.10 46.00 208.55
Working Capital Days 69.64 48.08 49.56 65.18 244.28
ROCE % 9.60% 30.39% 58.58% 6.33%

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Dec 2024Mar 2025
69.91% 69.91% 69.91% 69.91%
30.09% 30.09% 30.09% 30.09%
No. of Shareholders 580505487459

Documents

Announcements

Annual reports